文献速递肝病

Fibro-PeN的开发:一种用于儿童非酒精性脂肪性肝病中重度纤维化的临床预测模型

Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease.
PubMed 文献 · Hepatology · 2023-10-23

研究纳入1055例经活检证实的儿童非酒精性脂肪性肝病(NAFLD)患者,评估现有儿童及成人纤维化预测模型并开发新模型Fibro-PeN。现有模型AUC仅0.57-0.64,新模型由14个常见临床变量构成,AUC为0.79(95%CI:0.77-0.81),识别中重度纤维化的敏感度72%、特异度76%。

要点

  • 现有儿童及成人纤维化预测模型在儿童NAFLD中判别能力有限,AUC为0.57-0.64。
  • 新模型Fibro-PeN基于14个常见临床变量,AUC为0.79(95%CI:0.77-0.81)。
  • Fibro-PeN识别中重度纤维化的敏感度72%、特异度76%。

核心结论

  • 现有纤维化预测模型在儿童NAFLD中临床效用有限,Fibro-PeN通过识别中重度纤维化改善了风险分层的性能特征。

研究设计与样本

  • 在非酒精性脂肪性肝炎临床研究网络(Nonalcoholic Steatohepatitis Clinical Research Network)中纳入肝活检后90天内、经活检证实NAFLD的儿童,共评估1055例。
  • 采用非酒精性脂肪性肝炎临床研究网络评分系统共识判读肝纤维化分期。
  • 使用最小绝对收缩和选择算子(LASSO)结合线性项与样条项开发新模型,并以10折交叉验证进行内部验证。

主要发现

  • 1055例NAFLD患儿中26%存在中重度纤维化。
  • 现有模型在儿童中分类纤维化的表现不佳,受试者工作特征曲线下面积(AUC)范围为0.57至0.64。
  • 新模型由14个常见临床变量衍生,识别中重度纤维化的AUC为0.79(95%CI:0.77-0.81),敏感度72%,特异度76%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Liver fibrosis is common in children with NAFLD and is an important determinant of outcomes. High-performing noninvasive models to assess fibrosis in children are needed. The objectives of this study were to evaluate the performance of existing pediatric and adult fibrosis prediction models and to develop a clinical prediction rule for identifying moderate-to-severe fibrosis in children with NAFLD. APPROACH AND RESULTS: We enrolled children with biopsy-proven NAFLD in the Nonalcoholic Steatohepatitis Clinical Research Network within 90 days of liver biopsy. We staged liver fibrosis in consensus using the Nonalcoholic Steatohepatitis Clinical Research Network scoring system. We evaluated existing pediatric and adult models for fibrosis and developed a new pediatric model using the least absolute shrinkage and selection operator with linear and spline terms for discriminating moderate-to-severe fibrosis from none or mild fibrosis. The model was internally validated with 10-fold cross-validation. We evaluated 1055 children with NAFLD, of whom 26% had moderate-to-severe fibrosis. Existing models performed poorly in classifying fibrosis in children, with area under the receiver operator curves (AUC) ranging from 0.57 to 0.64. In contrast, our new model, fibrosis in pediatric NAFLD was derived from fourteen common clinical variables and had an AUC of 0.79 (95% CI: 0.77-0.81) with 72% sensitivity and 76% specificity for identifying moderate-to-severe fibrosis. CONCLUSION: Existing fibrosis prediction models have limited clinical utility in children with NAFLD. Fibrosis in pediatric NAFLD offers improved performance characteristics for risk stratification by identifying moderate-to-severe fibrosis in children with NAFLD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Wang A, Blackford AL, Behling C, et al. Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease. Hepatology. 2023. PMID: 37870272. doi:10.1097/HEP.0000000000000644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。